Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Brunei.
Press releases published on June 20, 2025
Global AI Spotlight: DataGlobal Hub Assembles Hundreds of Industry Leaders for GDAI 2025, The Largest Global Virtual AI & Data Conference
GlobeNewswire
·
June 20, 2025
PHOENIX, June 20, 2025 (GLOBE NEWSWIRE) -- DataGlobal Hub, a fast-growing global media platform at the forefront of Data and Artificial Intelligence (AI) news and insights, is proud to officially unveil the top speakers for Global Data …
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
GlobeNewswire
·
June 20, 2025
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late- …
XRP and DOGE are back with a bang, and the environmentally friendly cloud mining platform attracts millions of users with easy mining
GlobeNewswire
·
June 20, 2025
Newark, New Jersey, June 20, 2025 (GLOBE NEWSWIRE) -- XRP is back in the spotlight after winning a lawsuit against the U.S. Securities and Exchange Commission (SEC), while Dogecoin is also back in the spotlight due to renewed speculation about Elon Musk’s …
XY Miners: Real-time Bitcoin (BTC) Dogecoin (DOGE) mining, no hardware required
GlobeNewswire
·
June 20, 2025
New York City, NY, June 20, 2025 (GLOBE NEWSWIRE) -- In 2025, the cryptocurrency market continues to heat up, and "Bitcoin mining" has once again become a hot keyword for investors and blockchain enthusiasts. Bitcoin (BTC) is not only the most influential …
Treatment.com AI Grants Stock Option and RSUs
GlobeNewswire
·
June 20, 2025
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted 799,920 restricted share units (“RSUs”) and 162,480 stock options (“Options”) to …
Intermap Appoints New Auditors
GlobeNewswire
·
June 20, 2025
DENVER, June 20, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies Corporation (TSX: IMP) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that MNP LLP (“MNP”) have been appointed as auditors …
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
GlobeNewswire
·
June 20, 2025
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously …
Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering
GlobeNewswire
·
June 20, 2025
LONDON, Ontario, June 20, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …
AGM Group Holdings Inc. Regains Compliance with Nasdaq Bid Price Requirement
GlobeNewswire
·
June 20, 2025
Beijing, June 20, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewswire
·
June 20, 2025
KUALA LUMPUR, June 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities purchase …
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 20, 2025
WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
GlobeNewswire
·
June 20, 2025
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc …
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
GlobeNewswire
·
June 20, 2025
Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with …
PharmAla Files Preliminary Base Shelf Prospectus
GlobeNewswire
·
June 20, 2025
TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
GlobeNewswire
·
June 20, 2025
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
GlobeNewswire
·
June 20, 2025
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the …
Sagteс Finalizes Strategic AI Acquisition to Accelerate SaaS Revenue and Multi-Sector AI Deployment
GlobeNewswire
·
June 20, 2025
KUALA LUMPUR, Malaysia, June 20, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a next-generation provider of customizable AI and automation platforms, today announced the signing of a definitive Share Sale …
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules
GlobeNewswire
·
June 20, 2025
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules Nantes, June 20th, 2025, 7:30 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), publishes a “Questions and …
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire
·
June 20, 2025
VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest study of CIDP patients to date First novel …
BSTR Miner Unveils New Low-Barrier Cloud Mining Platform to Expand Global Crypto Participation
GlobeNewswire
·
June 20, 2025
San Francisco, CA, June 20, 2025 (GLOBE NEWSWIRE) -- BSTR Miner, a global provider of cloud-based digital asset mining services, has officially launched its enhanced cloud mining platform, built to make cryptocurrency mining simpler, more secure, and more …